US Archives - Page 80 of 157 - European Medical Journal

Lactation Support Lacking for ICU Mothers, Study Finds

Lactation outcomes in critically ill postpartum patients remain an understudied aspect of intensive care, but a new retrospective study highlights both the promise and pitfalls of current ICU practices.

Improving Bedside Nursing With ISBAR Communication

Improving communication between nurses is critical to patient safety and care quality, particularly in complex specialties like rheumatology and immunology.

Exploring JAK Inhibitors for Safer, More Effective Vitiligo Treatment

New analysis shows promising repigmentation with JAK inhibitors in vitiligo, especially in combination with UVB. Safety and long-term outcomes remain key research needs.

CMV After Transplant: Could Targeted T-Cell Therapy Change the Game?

New research explores how virus-specific T-cell therapy may help prevent or treat cytomegalovirus after transplant, revealing high response rates in HSCT patients but limited data in solid organ recipients.

Sharp Drop in Young Women’s Breast Cancer Deaths: AACR 2025

Breast cancer mortality in women aged 20 to 49 has significantly declined across all racial and molecular subgroups, according to findings presented at the AACR Annual Meeting 2025 in Chicago, Illinois.

Real-Time Ultrasound Links Vessels to Glioma Severity

Accurate tumor grading in glioma is essential for guiding treatment and predicting outcomes, yet current methods rely heavily on biopsy and histopathology.

New Study Links Immune Pathways to Post-COVID Lung Scarring

In a new study researchers have identified distinct immune system pathways that may determine the severity of long-term lung damage following COVID-19.

Dermatologic Risks for Polar Explorers in Arctic and Antarctic Missions

Dermatological conditions in polar environments are gaining new attention as research missions to the Arctic and Antarctic expand.

How Rheumatologists Choose Specialists to Refer To

Understanding referral patterns in rheumatic disease management is crucial to improving interdisciplinary care and patient outcomes.

Phase III Pembrolizumab Trial in Head and Neck Cancer: AACR 2025

Patients with newly diagnosed, locally advanced head and neck squamous cell carcinoma (HNSCC) may soon benefit from a major shift in treatment strategy, as phase III trial data show that perioperative pembrolizumab significantly improves outcomes when added to standard care.